Inhibition of CCL2 blocked macrophage recruitment and angiogenesis, resulting in decreased tumor and blood volumes in an orthotopic human GBM model (U-87 MG cell line) expressing CCL2. This evidence concerns the gene CCL2 and glioblastoma.